Inventor

CASTILLO GERARDO

US26 patents

⚠️ This page may combine multiple inventors who share the name “CASTILLO GERARDO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CASTILLO GERARDO

UNIV WASHINGTON

Specific saccharide compositions and methods for treating Alzheimer&#39;s disease and other amyloidoses

Composition and methods for treating Alzheimer&#39;s disease and other amyloidoses

Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer&#39;s Disease and other amyloidoses

Composition and methods for inhibiting the formation of brain amyloid deposits

Compositions for treating alzheimer&#39;s disease and other amyloidoses

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Therapeutic applications of laminin and laminin-derived protein fragments

Peptides for the treatment of Alzheimer&#39;s disease and other β-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer&#39;s and Prion diseases

Methods for producing pure perlecan and other heparan sulfate proteoglycans

Methods of isolation of amyloid inhibitory ingredients within Uncaria tomentosa

PROTEOTECH INC

Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants

Methods of treating Alzheimer&#39;s disease and other amyloidoses using Hypericum perforatum and derivatives thereof

Small peptides for the treatment of alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Small peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein disorders

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer&#39;s disease, type 2 diabetes, and Parkinson&#39;s disease

CASTILLO GERARDO

Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants

Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants

Methods for using glucose pentasulfate for treating amyloid associated with type II diabetes

Isolation, purification and synthesis of procyanidin B2 and uses thereof

SNOW ALAN D

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer&#39;s disease, type 2 diabetes and Parkinson&#39;s disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes and parkinson&#39;s disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes, and parkinson&#39;s

(unassigned)

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Specific saccharide compositions and methods for treating Alzheimer's disease and other amyloidoses

Composition and methods for treating Alzheimer's disease and other amyloidoses

Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer's Disease and other amyloidoses

Compositions for treating alzheimer's disease and other amyloidoses

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer's disease and other β-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases

Methods of treating Alzheimer's disease and other amyloidoses using Hypericum perforatum and derivatives thereof

Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein disorders

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders